Application of xanthoxylin WGX-50 in preparation of anti-aging drugs

By using the drugs prepared by saicin WGX-50, the problem of insufficient effectiveness in the development of existing anti-aging drugs has been solved, and the effect of significantly prolonging life and delaying aging has been achieved. Through various dosage forms and introduction methods, the signs of aging are significantly reduced. The accumulation of substances demonstrates its pharmacological activity in delaying aging and prolonging life.

CN118948819APending Publication Date: 2024-11-15SHANGHAI JIAOTONG UNIV

Patent Information

Application Number
CN202411326789.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-23
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

No effective anti-aging drugs have been approved or proven to be effective in clinical studies, resulting in huge challenges in the development of anti-aging drugs.

Method used

Using saicin WGX-50 as the main ingredient, a drug that can be used to treat and prevent premature aging is prepared. It supports the preparation of various dosage forms through pharmaceutically acceptable salts, esters, hydrates or carrier forms, and through injection, Introduce the spray, nose drop and other methods into the body, significantly reducing the accumulation of aging markers and prolonging life.

Benefits of technology

Sesarcin WGX-50 significantly prolongs the lifespan of nematodes and mice, reduces the accumulation of aging markers lipofuscin and reactive oxygen free radicals, maintains the weight and spinal health of elderly mice, demonstrating that it is delaying aging and prolongs lifespan pharmacological activity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118948819A_ABST
    Figure CN118948819A_ABST
Patent Text Reader

Abstract

The invention discloses a novel medicinal application of xanthoxylin WGX-50, belongs to the field of biological medicines, and particularly discloses an application of xanthoxylin WGX-50 in preparation of anti-aging medicines. The research proves that the xanthoxylin WGX-50 can play a role through a plurality of molecular mechanisms including an insulin longevity signal channel, MAPK, antioxidant and heat shock protein, has a remarkable regulation and control capability on longevity genes daf-16 and skn-1 (mouse homologous genes FOXO1 and Nrf2), and has pharmacological effects of resisting aging and prolonging life.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biomedicine, in particular to the field of new drug application technology, and in particular to the application of pepper WGX-50 in the preparation of anti-aging drugs. Background Art

[0002] Developing anti-aging drugs to make people healthy and long-lived is an important research topic. So far, a variety of anti-aging drugs have made important progress in the preclinical research stage, such as nicotinamide mononucleotide (NMN), rapamycin, metformin, resveratrol, etc., all of which have significant anti-aging and life-extending pharmacological activities at the model animal level. However, so far no anti-aging drugs have been approved or proven to be effective in the clinical research stage, and even the anti-aging drug NMN has been proven to be ineffective in recent clinical studies. In this field, the challenges people face are still huge. Summary of the invention

[0003] The main purpose of the present invention is to provide a new medicinal use of peppermint WGX-50.

[0004] To achieve the above-mentioned object, the present invention provides the use of zanthoxylum bungeanum WGX-50 in preparing a drug for treating and / or preventing premature aging.

[0005] The present invention also provides a drug for preventing and treating premature aging. The drug contains pepper WGX-50 and its pharmaceutically acceptable salts, esters, and hydrates. The above-mentioned drug can also be added with one or more pharmaceutically acceptable carriers. The carrier includes conventional diluents, excipients, fillers, adhesives, wetting agents, disintegrants, absorption promoters, surfactants, adsorption carriers, lubricants, etc. in the pharmaceutical field. The above-mentioned drug can support various forms such as injection, tablets, powders, granules, capsules, oral liquids, ointments, creams, etc.; the above-mentioned various dosage forms of drugs can be prepared according to conventional methods in the pharmaceutical field. The above-mentioned drug can be introduced into the body such as muscle, intradermal, subcutaneous, vein, mucosal tissue by injection, spraying, nasal drops, eye drops, penetration, absorption, physical or chemical mediation; or it can be introduced into the body after being mixed or wrapped with other substances. BRIEF DESCRIPTION OF THE DRAWINGS

[0006] Figure 1 The molecular formula of Zanthoxylum bungeanum WGX-50 and the schematic diagram of Zanthoxylum bungeanum and nematode;

[0007] Figure 2 The pepper extract WGX-50 extended the lifespan of nematodes (20C);

[0008] Figure 3The results showed that WGX-50 prolonged the lifespan of nematodes in a dose-dependent manner (25C).

[0009] Figure 4 The result is that WGX-50 has no effect on the reproduction, growth and development of nematodes at the optimal dose of 50 μM.

[0010] Figure 5 At the in vivo level in nematodes, WGX-50 at a dose of 50 μM significantly reduced the accumulation of lipofuscin, a marker of aging, in vivo (5 days, 25°C);

[0011] Figure 6 In vitro, WGX-50 significantly reduced the accumulation of lipofuscin, a marker of aging, at a dose of 50 μM in nematodes (5 days, 25°C).

[0012] Figure 7 At the in vivo level of nematodes, WGX-50 significantly reduced the accumulation of reactive oxygen free radicals (ROS) in vivo at a dose of 50 μM (10 days, 25°C).

[0013] Figure 8 The results showed that WGX-50 significantly prolonged the lifespan of C57BL / 6 naturally aged mice (7 months old) at a dose of 50 mg / kg (oral administration) (n=10).

[0014] Fig. 9 The results showed that WGX-50 significantly maintained the body weight of C57BL / 6 naturally aged mice (1 year old) in the early stage of old age (weeks 6 to 13) at a dose of 50 mg / kg (oral drinking, 32 weeks) (n=13).

[0015] Fig.10 The results showed that WGX-50 significantly improved the spinal health score of C57BL / 6 naturally aged mice (1 year old) at a dose of 50 mg / kg (oral drinking, 14 weeks); Fig.11 The results showed that WGX-50, a 50 μM dose of cypermethrin, extended the lifespan of nematodes by inhibiting the insulin longevity signaling pathway, activating or partially activating the MAPK, antioxidant and heat shock protein pathways.

[0016] Fig.12 In vivo, WGX-50 promoted the expression of longevity genes daf-16 and skn-1 at the protein level at a dose of 50 μM.

[0017] Fig.13 The longevity genes daf-16 and skn-1 are key genes that mediate the effect of WGX-50 on extending the lifespan of nematodes.

[0018] Fig.14 In D-gal-induced aged mice, WGX-50 at a dose of 50 mg / kg (oral drinking, 8 weeks, n=5) activated the expression of daf-16 and skn-1 (mouse homologous genes are Foxo1 and Nrf2), the key longevity genes confirmed in nematodes, at their transcriptional level. DETAILED DESCRIPTION

[0019] The technical solutions in the embodiments of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention. In addition, the technical solutions between the various embodiments can be combined with each other, but they must be based on the ability of ordinary technicians in this field to implement them. When the combination of technical solutions is contradictory or cannot be implemented, it should be considered that such combination of technical solutions does not exist and is not within the scope of protection required by the present invention.

[0020] Embodiment 1

[0021] Reagents and materials

[0022] Zanthoxylum bungeanum WGX-50 was obtained from the laboratory of Professor Wei Dongqing of Shanghai Jiao Tong University. In the nematode test, 0.1% ethanol (Shanghai Shenggong Biological) was used to dissolve Zanthoxylum bungeanum WGX-50 to a concentration of 50 μM, and other concentrations of Zanthoxylum bungeanum solutions were obtained by dilution. Levamisole (Aladdin reagent); H2DCF-DA (Biyuntian Biotechnology).

[0023] Test methods

[0024] 1. C. elegans lifespan test

[0025] There is no need to apply for ethics for nematode experiments, and all nematodes are from CGC (https: / / cgc.umn.edu / ). The experiment of extending the lifespan of nematodes at 20°C with pepper WGX-50 is as follows: wild-type nematodes (N2C.elegans) are treated with peppers of different concentration gradients to determine the appropriate concentration of peppers, and the data are recorded to make a lifespan curve. This experiment is divided into 10 experimental groups (2mM, 1mM, 0.5mM, 50μM, 125μM, 62.5μM, 31.25μM, 15μM, 7.5μM, 3.75μM) and 1 control group (0.1% ethanol). Wild-type nematodes are first cultured synchronously on nematode solid growth medium (NGM) containing OP50 (nematode food). When the synchronized nematodes develop to the L4 stage, 30 nematodes of good growth and uniform size are picked up with a worm picker (Beijing Disconovo Company) under a stereo microscope (Motic Company) and placed on NGM solid culture medium containing 5-fluoro-2'-deoxyuridine (FUDR, Beijing Puxitang Biology) in each experimental group. This process requires that the nematodes are at the same age and developmental period to avoid experimental errors. Five culture plates are set up in each group, that is, about 150 nematodes are included in each group as observation objects. The nematodes are then cultured in a 20°C constant temperature incubator (Shanghai Jinghong Medical Equipment Factory) until all die. At this time, the life span of the nematodes is recorded as day 0. Subsequently, the growth of the nematodes needs to be observed every day, including the number of normal or abnormal deaths of the nematodes, and the nematodes are transferred to a new culture medium at an appropriate time to ensure sufficient food supply. After the experiment, the data are sorted, a survival curve is made, the experimental results are compared, and conclusions are drawn, and the optimal drug concentration of WGX-50 for extending the life span of nematodes is determined. The experiment was repeated three times independently. Similarly, in another laboratory, different experimenters independently conducted a life span test at the nematode level at 25°C in accordance with the law to explore the potential pharmacological effects of WGX-50 on aging.

[0026] 2. Measurement of basic physiological indicators of nematodes

[0027] Select the synchronized L4 nematodes, randomly pick them into the NGM plates of the control group and the WGX-50 (50 μM) treatment group, and treat them with drugs at 25 ° C for 5 days. The measurement of nematode body length and width is as follows: 10 to 30 worms are randomly selected from each group, anesthetized with an appropriate amount of 10mM levamisole (Aladdin reagent) solution, and then carefully straighten the nematode body and place it neatly in the center of the NGM plate under a stereo microscope. Take pictures with a microscope at the same magnification and brightness, and finally use ImageJ software (v1.54g, NIH, 2023) to measure the body length and width of the nematodes.

[0028] The measurement of the pharyngeal pumping rate of nematodes is as follows: 10 to 30 worms are randomly selected from each group, and the number of pharyngeal pumping times of each nematode within 20 to 60 seconds is counted under a stereo microscope. The movement ability of nematodes is evaluated as follows: Take a clean NGM plate (without OP50 bacterial base) and add an appropriate amount of M9 buffer solution, such as 50 to 100 μL, to its center. Next, the nematodes to be observed (10 to 30 worms are randomly selected from each group) are picked into the drop of M9 solution, and the nematodes immediately twist their bodies in the liquid. After adapting for a few seconds, count the number of nematode body swings within 1 minute under a stereo microscope.

[0029] The method for determining the egg-laying amount of nematodes is as follows: randomly select 10 to 30 worms from each group on the NGM plate, closely observe their conditions and count the egg-laying amount. The entire observation period lasts until all nematodes stop laying eggs. The test of the hatching efficiency of anthocyanin on nematode eggs is as follows: about 200 nematode eggs are randomly inoculated on the NGM plate, incubated at a constant temperature of 25°C overnight, and then the number of L1-L2 worms is counted as the number of hatched eggs, and the percentage is calculated as the hatching rate.

[0030] 3. Determination of Lipofuscin in C. elegans

[0031] The nematodes were treated with WGX-50 (50 μM) at 25°C according to the method and then harvested for 6 days. After that, the positive and inverted integrated fluorescence microscope can be used directly to take pictures under the blue fluorescence channel (DAPI). Finally, the image data was processed with ImageJ software, and the statistical test results were reported. In addition, for the nematode whole protein samples (n=5) treated with WGX-50 (50 μM) according to the method, the blue fluorescence signal was collected using a multifunctional microplate reader (Spark, TECAN), and the statistical test results were reported. The extraction method of the nematode whole protein sample is as follows: the nematodes are placed in RIPA lysis buffer (50mM Tris-HCl, pH 7.4; 150mMNaCl; 1% Triton X-100; 1% sodium deoxycholate; 1.1% SDS; 1X PMSF, 1X phosphataseinhibitor cocktail I / II, 1X protease inhibitor cocktail, MCE, USA), and homogenized with grinding beads at 4°C using a tissue grinder (Shanghai Jingxin Technology) to fully release the protein from the nematode tissue. The obtained protein solution was centrifuged at 12000rpm / min at 4°C for 10min, and the supernatant solution was retained for later use. Before measuring the blue autofluorescence signal of lipofuscin, it is necessary to first follow the Pierce TMThe protein concentration of each sample was measured using the BCA kit (Thermo Scientific, USA), and then an appropriate volume of a sample with the same protein content was taken for testing.

[0032] 4. Determination of Reactive Oxygen Free Radicals (ROS) in C. elegans

[0033] The experiment was divided into a control group (Ctrl) and a pepper WGX-50 group (50 μM). Wild-type nematodes (N2C.elegans) were treated according to the law for 5 and 10 days. After reaching the end of the experiment, the nematodes were repeatedly rinsed 3 times with M9 buffer, harvested in a 1.5 mL centrifuge tube, and then H2DCF-DA (Biyuntian Biotechnology) with a final concentration of 50 μM was added, placed in a biochemical incubator and incubated at 25°C for 3 hours, and then washed twice with M9 buffer after the end. 10 to 30 nematodes were randomly selected, moved to a 2% agar pad, anesthetized with an appropriate amount of 10 mM levamisole solution, and the green fluorescence intensity of each group of nematodes was observed under an inverted fluorescence microscope (Revolve, ECHO). Finally, the fluorescence intensity was quantitatively analyzed using ImageJ software.

[0034] 5. Statistics

[0035] Unless otherwise specified, for the survival curve analysis of nematodes and mice, the Log-rank (Mantel-Cox) method was used for statistical hypothesis testing. For the significance analysis of observations between any two groups, the unpaired t test (two-tailed) was used. For the significance analysis of observations between multiple groups, one-way ANOVA analysis was used. The statistical significance level was set at α = 0.05. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, ns, not significant. The data results are presented in the form of mean ± standard error (SEM, standard error of mean). The data graphs were drawn with GraphPad Prism v9.5 (GraphPad Software, USA) software and exported after unified arrangement with Adobe Illustrator CC (Adobe Systems Inc., USA) software.

[0036] Experimental Results

[0037] According to the test results, peppermint (WGX-50, Figure 1) prolonged the lifespan of wild-type nematodes (N2 C.elegans) in a dose-dependent manner at 20°C (test concentration range: 3.75μM~2mM). The best effective dose of WGX-50 obtained here was 62.5μM, at which WGX-50 prolonged the median survival time of nematodes by 45% (22→32 days, Figure 2 ). Subsequently, we independently confirmed the life-extending effect of WGX-50 in another laboratory. Specifically, at 25°C, WGX-50 also extended the lifespan of nematodes in a dose-dependent manner. At its optimal effective concentration of 50 μM, WGX-50 extended the median survival time of nematodes by 78% (9→16 days, Figure 3 In contrast, at a lower dose, 5 μM of WGX-50 also prolonged the median survival time of nematodes by 56% (9→14 days, Figure 3 ).

[0038] Importantly, at a dose of 50 μM, WGX-50 did not affect the reproduction, growth, and development of nematodes, that is, the length, width, egg production, egg hatching efficiency, diet, and exercise capacity of nematodes were not affected ( Figure 4 ). This shows that at this optimal effective dose, WGX-50 is safe for nematodes. More importantly, after treating nematodes with 50μM WGX-50, the level of lipofuscin was significantly reduced. Lipofuscin is an important marker of aging, which gradually accumulates in the body of nematodes as they age. Based on this data, we analyzed the in vivo level of nematodes (in vivo, DAPI channel, blue autofluorescence signal, Figure 5 ) and extracted whole protein levels (in vitro, Ex / Em=340 / 420nm, blue fluorescence signal, Figure 6 ) were confirmed one by one. In addition, after treating nematodes with 50μM WGX-50 for 10 days, the reactive oxygen free radicals (ROS) in their bodies were also significantly reduced ( Figure 7 ). So far, we believe that WGX-50 significantly improves the health of nematodes (N2C.elegans), that is, delays aging and prolongs lifespan.

[0039] Embodiment 2

[0040] Reagents and materials

[0041] Zanthoxylum bungeanum WGX-50 comes from the laboratory of Professor Wei Dongqing of Shanghai Jiao Tong University. In the experiment on naturally aging mice, the Zanthoxylum bungeanum WGX-50 solution used contained 6% cyclodextrin (2-HPbCD, Xi'an Ruiying Biology) and 0.1% DMSO (WAK-chemie medical GmbH, Germany). Correspondingly, the control solution drunk by mice was an aqueous solution containing 6% cyclodextrin and 0.1% DMSO. The solute medium of the Zanthoxylum bungeanum WGX-50 gavage preparation used in the mouse experiment was: 1% DMSO, 99% saline (Sichuan Kelun Pharmaceutical) and 0.5% hydroxypropyl methylcellulose (HPMC, Beijing Wokai Biological) solution. 7-month-old C57BL / 6 male mice were from Shanghai Slake Experimental Animal Company, with an average weight of about 25 to 30g. One-year-old C57BL / 6 naturally aging mice were from Shanghai Southern Model Organisms, with an average weight of about 30g.

[0042] Test methods

[0043] 1. Drug Treatment of Young Naturally Aged Mice

[0044] First, we used naturally aged mice to confirm the anti-aging pharmacological effects of pepper WGX-50 at the nematode level. Briefly, 20 7-month-old male C57BL / 6 mice (Shanghai Slake Experimental Animal Company, with an average weight of about 25-30g) were randomly divided into a control group (Ctrl, n=10) and a treatment group (WGX-50, n=10), followed by a gavage test. Here, the dosage of pepper WGX-50 is 50mg / kg / day. During the administration period, the mice were cared for normally, and a small number of deaths were recorded for survival analysis.

[0045] 2. Drug Treatment of Old Naturally Senescent Mice

[0046] In addition, we also used 26 one-year-old male C57BL / 6 naturally aged mice (Shanghai Southern Model Organism, average weight of about 30g), which were randomly divided into two groups, namely the control group (Ctrl, n = 13) and the drug group (WGX-50, n = 13). The mice in the control group were given a control solution (6% cyclodextrin, 0.1% DMSO), and the mice in the drug group were given a solution of WGX-50 with pepper, and the dose of pepper was 50mg / kg / day. During the experiment, the mouse drinking bottle needed to be cleaned every 4 to 5 days, and the original solution was replaced with a fresh drug solution. The entire experimental period lasted 32 weeks, during which the health of the mice was observed every day, and all mice ate normally during this period.

[0047] The scoring method for spinal curvature in aged mice is as follows (J Vis Exp. 2010; (39): 1787): The mice were taken out of the cage and placed on a horizontal table. During the free walking of the mice, animal experts observed and scored according to the following rules: 0 points if the mice could freely extend their spines and had no persistent spinal curvature; 1 point if the mice could freely extend their spines and had slight spinal curvature; 2 points if the mice could not freely extend their spines and had persistent but slight spinal curvature; 3 points if the mice could not freely extend their spines and had persistent and obvious spinal curvature.

[0048] All mice were housed in IVC cages (Suzhou Fengshi Experimental Animal Equipment Co., Ltd.) and provided with adequate food and water. The experimental animal breeding room ensured 12h white light / dark light lighting conditions and the room temperature was maintained at 22.0±1℃. All mice were required to undergo at least one week of adaptive feeding from the first day of placement in the laboratory before the experiment was carried out as planned.

[0049] All mouse experiments were approved by the Experimental Animal Ethics and Use Committee of Shanghai Jiao Tong University. The use and manipulation of experimental animals were in accordance with the standards of the Experimental Animal Center of Shanghai Jiao Tong University and international peers.

[0050] Experimental Results

[0051] First, 20 7-month-old male C57BL / 6 mice were randomly divided into a control group (Ctrl) and a drug-treated group (WGX-50, n=10). After one week of adaptive feeding, a gavage test was performed. Here, the dosage of pepper was 50 mg / kg. From the test results, pepper WGX-50 has the pharmacological effect of prolonging the life span and health cycle of mice. On the one hand, it increased the median survival time of mice by 48% (526→779 days, Figure 8 ); On the other hand, pepper extract also significantly prolonged the healthy life span of mice, that is, in the pepper extract WGX-50 administration group, the first recorded death of mice was significantly delayed from the 264th day to the 649th day ( Figure 8 ).

[0052] In another independent experiment on naturally aged mice, we used older mice (1 year old) and orally administered WGX-50 solution to them for up to 32 weeks. The experimental data showed that WGX-50 significantly had a positive effect on the early body weight maintenance of aged mice ( Fig. 9), that is, peppercorns significantly maintained the body weight of elderly mice during the 8 consecutive weeks (weeks 6 to 13) of administration. In addition, as early as the 6th week, we observed spinal curvature, loss of balance in body support, and unilateral support of body movement in mice in the control group; since then, such events have continued to occur and the number has gradually increased until the 14th week (the end of observation). In contrast, it was not until the 10th week that we observed only one mouse with spinal curvature in the peppercorns WGX-50 administration group; from then on, until the 14th week, in addition to this mouse, only the second mouse showed spinal curvature at the 13th week. Regarding the changes in the spinal health status of the above-mentioned mice, after animal experts scored them according to the scale, we found that peppercorns WGX-50 significantly delayed the spinal aging of mice, that is, as far as the mice administered with peppercorns WGX-50 were concerned, their scores were significantly lower than those of the mice in the control group ( Fig.10 ).

[0053] Embodiment 3

[0054] Reagents and materials

[0055] Zanthoxylum bungeanum WGX-50 comes from the laboratory of Professor Wei Dongqing of Shanghai Jiao Tong University. In the experiment of aging mice induced by galactose (D-gal, Shanghai Xushuo Biological), the Zanthoxylum bungeanum WGX-50 solution used contained 6% cyclodextrin (2-HPbCD, Xi'an Ruiying Biological) and 0.1% DMSO (WAK-chemie medical GmbH, Germany). Correspondingly, the control solution drunk by the mice was an aqueous solution containing 6% cyclodextrin and 0.1% DMSO. 8-week-old C57BL / 6 male mice were from Shanghai Slake Experimental Animal Company, with an average weight of about 25 to 30g.

[0056] Test methods

[0057] 1. RT-qPCR

[0058] Total RNA was extracted from nematodes and mouse tissues such as small intestine using RNAiso Plus reagent (Takara, Japan) according to the manufacturer's instructions. TM 1 μg of total RNA was reverse transcribed into cDNA using a reverse transcription kit (Takara, Japan). qPCR SYBR Green MasterMix Kit (Yisheng Bio) was used to perform quantitative reverse transcription polymerase chain reaction (RT-qPCR) to determine the expression of multiple genes at the mRNA level in nematodes and mouse tissues. ΔΔCT Methods The relative expression of genes was calculated, and gpd-1 and gapdh were used as internal references. The primers required for the experiment are as follows:

[0059] Table 1 List of primers used in RT-qPCR experiments.

[0060]

[0061]

[0062]

[0063] 2. Fluorescence Microscopy Analysis

[0064] The genetically engineered nematodes used in this experiment are: TJ356 (zIs356 [daf-16p:: daf-16a / b:: GFP + rol-6 (su1006)] (abbreviated as daf-16:: GFP), LD1 (ldIs7 [skn-1b / c:: GFP + rol-6 (su1006)] (abbreviated as skn-1:: GFP). The daf-16:: GFP and skn-1:: GFP nematodes were cultured at 20°C and 25°C, respectively. The nematodes were treated with WGX-50 (50 μM) according to the law for 5 days and then harvested. Thereafter, according to the method under the ROS determination, an upright and inverted integrated fluorescence microscope was used to take pictures under the green fluorescence channel (GFP). Finally, the image data was processed with ImageJ software, and the statistical test results were reported. In data statistics, the fluorescence intensity of the daf-16 protein in the cytoplasm and the nucleus (punctate fluorescence) needs to be calculated separately.

[0065] 3. Lifespan Test of C. elegans Mutants

[0066] In order to study the role of daf-16 and skn-1 genes in the life extension of nematodes mediated by WGX-50, we used the gene mutant nematodes GR1307 (daf-16 (mgDf50) (abbreviated as daf-16mutant) and EU1 (skn-1 (zu67) IV / nT1 [unc-? (n754) let-?] (IV; V) (abbreviated as skn-1mutant) to conduct experiments. The experimental design was divided into 6 groups, namely, daf-16_Ctrl, daf-16_WGX-50; N2_Ctrl, N2_WGX-50; skn-1_Ctrl, skn-1_WGX-50 (the naming rule of each group is: nematode strain name_drug treatment). The drug dose of WGX-50 was 50 μM, and its control agent was 0.1% ethanol. The life span test was carried out according to the method described above.

[0067] 4. Drug-induced aging mouse experiment

[0068] Finally, we used D-gal (Shanghai Xushuo Biological) to induce aging in mice by subcutaneous injection in the neck, and studied the anti-aging effect of pepper WGX-50 after oral administration to mice. Specifically, 25 8-week-old C57BL / 6 male mice (Shanghai Slake Experimental Animal Company, with an average weight of about 25-30g) were randomly divided into 5 groups (n=5), including a control group (Ctrl) and 4 aging-induced + drug administration groups (W0, W10, W25, W50). For the 4 groups of aging-induced + drug administration group mice, the daily injection (sc) dose of D-gal was 400 mg / kg, and the oral administration dose of pepper WGX-50 ranged from 0 to 50 mg / kg. For the control group mice, an equal volume of 0.9% saline was injected (sc) at the same time, and they were given a control solution to drink. The experiment lasted for a total of 8 weeks, after which the mice were dissected according to the law and the small intestinal tissue was collected for later use.

[0069] Experimental Results

[0070] This example verifies that WGX-50 has the pharmacological effects of extending lifespan and delaying aging at the level of nematodes and mice.

[0071] So far, many longevity biological pathways have been widely recognized by the academic community. The longevity signaling pathway in nematodes (N2, C.elegans) has been included in the Japanese KEGG (https: / / www.kegg.jp / entry / cel04212) biological database. After treating nematodes with 50μM WGX-50 for 5 days, we systematically measured the expression of multiple genes in the longevity pathway by RT-qPCR.

[0072] The results showed that the expression of daf-2, a gene directly related to the longevity of nematodes, decreased at the transcriptional level. Correspondingly, other key genes in the insulin signaling pathway, daf-16, and its downstream antioxidant genes such as sod-3, ctl-1, gst-7, gst-8, gst-12, and gst-33, all had higher transcriptional expression levels ( Fig.11 ). In addition, WGX-50 can also promote the longevity of nematodes in part by activating the MAPK (mitogen-activated protein kinase) signaling pathway. Specifically, after 5 days of treatment with 50 μM of WGX-50, although the transcriptional expression levels of the MAPK pathway genes sek-1 and pmk-1 decreased, the jnk-1 gene was activated at the transcriptional level ( Fig.11 ), so the daf-16 gene located downstream of jnk-1 can be further activated ( Fig.11In addition, we also detected that WGX-50 can directly activate the skn-1 gene upstream of the antioxidant gene gst ( Fig.11 ), and the heat shock protein pathway is also activated (hsf-1→hsp12.2 / hsp90, Fig.11 ).

[0073] In the above-mentioned activated longevity signaling pathways, the genes daf-16 and skn-1 play an important hub role. Importantly, we also observed their high expression at the protein level in nematodes in vivo. In detail, after treating the transgenic nematodes daf-16::GFP and skn-1::GFP (a green fluorescent protein reporter gene strain of nematodes) with 50μM WGX-50 for 5 days, their protein expression levels were significantly increased ( Fig.12 ). Finally, we further verified these two genes in nematodes with knockout genes of daf-16 and skn-1 respectively - they are essential for the biological effect of WGX-50 on the life extension of nematodes. Simply put, when daf-16 and skn-1 knockout nematodes were given the same dose and duration (50μΜ, 5 days) as wild-type nematodes (N2 C.elegans), WGX-50 did not extend the lifespan of these gene knockout nematodes ( Fig.13 Finally, we even confirmed in the small intestine tissue of D-gal-induced aged mice that WGX-50 activated the transcriptional expression of the nematode longevity genes daf-16 and skn-1 (the mouse homologous genes are Foxo1 / Nrf2) ( Fig.14 ), although we did not see such changes in the small intestine of naturally aged mice at one year of age.

[0074] The above description is only a further embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical solutions and concepts of the present invention within the scope disclosed by the present invention, which belong to the protection scope of the present invention.

Claims

1. Use of peppermint WGX-50 in the preparation of drugs for treating and / or preventing premature aging, It is characterized in that The drug acts on multiple molecular mechanisms including the insulin longevity signaling pathway, MAPK, antioxidant and heat shock proteins.

2. The use according to claim 1, It is characterized in that The drug has a significant regulatory ability on the longevity gene daf-16.

3. The use according to claim 1, It is characterized in that The drug has a significant regulatory ability on the longevity gene skn-1 (mouse homologous genes FOXO1 and Nrf2).

4. A drug for preventing and treating premature aging, It is characterized in that The drug contains zanthoxylum bungeanum WGX-50.

5. The drug according to claim 4, It is characterized in that The medicine also includes pharmaceutically acceptable excipients.

6. The drug according to claim 4, It is characterized in that The auxiliary materials include one or more of diluents, fillers, excipients, binders, wetting agents, disintegrants, absorption promoters, surfactants, adsorption carriers, and lubricants.

7. The drug according to claim 4, It is characterized in that The dosage form of the drug includes tablets, injections, nasal drops or sprays.

8. The drug according to claim 4, It is characterized in that The method of taking the medicine is one of oral administration, injection, and nasal administration.

Citation Information

Patent Citations

  • WGX-50 liposome as well as preparation method and application thereof

    CN114224841A

  • Method for synthesizing xanthoxylin WGX-50 and derivatives thereof in one pot

    CN114315623A

Cited By

  • Caenorhabditis elegans disease model as well as construction method and application thereof

    CN118749495A